Cumba, Carmen G.
HRN: 17 34 49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/06/2022
10/12/2022
IVTT
4.5 G
Q8
Urosepsis,
Waiting Final Action
Indication: Empirical Escalation Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes